Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease
Journal of Neurochemistry · 06.11.2023
DOI: 10.1111/jnc.16002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 06.11.2023. Verfasst von Hongwei Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) affects various brain cell types, including astrocytes, which are the most abundant cell types in the central nervous system (CNS). Astrocytes not only provide homeostatic support to neurons but also actively regulate synaptic signaling and functions and become reactive in response to CNS insults through diverse signaling pathways including the JAK/STAT, NF‐κB, and GPCR‐elicited pathways. The advent of new technology for transcriptomic profiling at the single‐cell level has led to increasing recognition of the highly versatile nature of reactive astrocytes and the context‐dependent specificity of astrocyte reactivity. In AD, reactive astrocytes have long been observed in senile plaques and have recently been suggested to play a role in AD pathogenesis and progression. However, the precise contributions of reactive astrocytes to AD remain elusive, and targeting this complex cell population for AD treatment poses significant challenges. In this review, we summarize the current understanding of astrocyte reactivity and its role in AD, with a particular focus on the signaling pathways that promote astrocyte reactivity and the heterogeneity of reactive astrocytes. Furthermore, we explore potential implications for the development of therapeutics for AD. Our objective is to shed light on the complex involvement of astrocytes in AD and offer insights into potential therapeutic targets and strategies for treating and managing this devastating neurodegenerative disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
ORCID-Profile: Hongwei Qin
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Qin, H., Zhou, L., Haque, F. T., Martin-Jimenez, C., Trang, A., Benveniste, E. N., & Wang, Q. (2023). Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16002
Vancouver
Qin H, Zhou L, Haque FT, Martin-Jimenez C, Trang A, Benveniste EN, et al. Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease. Journal of Neurochemistry. 2023. doi:10.1111/jnc.16002
BibTeX
@article{Qin2023,
author = {Qin, Hongwei and Zhou, Lianna and Haque, Faris T and Martin-Jimenez, Cynthia and Trang, Amy and Benveniste, Etty N and Wang, Qin},
title = {Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease},
journal = {Journal of Neurochemistry},
year = {2023},
doi = {10.1111/jnc.16002}
}
EUVIMED